logo-hal

HALathon 2021 UPPA

Les articles que vous pouvez déposer

# Année Titre Revue Lien éditeur / doi Notice HAL
1 2021 Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex Archiv der Pharmazie / Chemistry in Life Sciences 10.1002/ardp.202000450 hal-03279625
2 2019 Synthesis, crystal structure and anti-leukemic activity of 4-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline Journal of Chemical Crystallography 10.1007/s10870-018-0734-2 hal-02130098
3 2018 Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives Chemical Biology & Drug Design 10.1111/cbdd.13164 hal-01690455
4 2016 Diminished oligomerization in the synthesis of new anti-angiogenic cyclic peptide using solution instead of solid-phase cyclization Biopolymers 10.1002/bip.22814 hal-01563735
5 2016 Design, Synthesis and Antimalarial Activity of Some New minoalcoholpyrrolo[ 1,2-A]quinoxaline Derivatives Letters in Drug Design and Discovery 10.2174/1570180813666160517164758 hal-01563736
6 2016 Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines European Journal of Medicinal Chemistry 10.1016/j.ejmech.2016.02.047 hal-01307573
7 2015 Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles Molecular BioSystems 10.1039/c5mb00358j hal-01563737
8 2015 Crystal structure of a fluoro analogue of 3,4-(methylenedioxy)amphetamine X-Ray Structure Analysis Online hal-01563739
9 2014 Design, synthesis and biological evaluation of novel 4- alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents - Part III European Journal of Medicinal Chemistry 10.1016/j.ejmech.2014.05.037 hal-01563740
10 2013 Supported oligomethionine sulfoxide and Ellman's reagent for cysteine bridges formation Amino Acids 10.1007/s00726-012-1397-5 hal-01563741
11 2013 Heating and microwave assisted SPPS of C-terminal acid peptides on trityl resin: The truth behind the yield Amino Acids 10.1007/s00726-013-1604-z hal-01563742
12 2011 Oxyfold: A simple and efficient solid-supported reagent for disulfide bond formation Chemistry - An Asian Journal 10.1002/asia.201100202 hal-01563744
13 2010 Insertion of multiple alpha-amino gamma-lactam (Agl) residues into a peptide sequence by solid-phase synthesis on synphase lanterns. Biopolymers 10.1002/bip.21288 hal-01563745
14 2009 Spectroscopic analysis of synthetic PrP helix2-binding peptide constructs. Advances in experimental medicine and biology 10.1007/978-0-387-73657-0_33 hal-01563747
15 2009 Peptide fragment approach to prion misfolding: The alpha-2 domain International Journal of Peptide Research and Therapeutics 10.1007/s10989-009-9171-6 hal-01563748
16 2009 A thermodynamic approach to the conformational preferences of the 180-195 segment derived from the human prion protein α2-helix Journal of Peptide Science 10.1002/psc.1086 hal-01563746
17 2008 Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein α2-helical 180-195 segment and comparison with full-length α2-helix-derived peptides Journal of Peptide Science 10.1002/psc.1046 hal-01563749
18 2007 Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and α helix 2 human prion protein fragments Proteins: Structure, Function and Genetics 10.1002/prot.21204 hal-01563752
19 2007 Conformational diseases and structure-toxicity relationships: Lessons from prion-derived peptides Current Protein and Peptide Science 10.2174/138920307779941505 hal-01563750
20 2006 The prion protein: Structural features and related toxic peptides Chemical Biology and Drug Design 10.1111/j.1747-0285.2006.00427.x hal-01563753
21 2006 Effect of salts on the structural behavior of hPrP α2-helix-derived analogues: The counterion perspective Journal of Peptide Science 10.1002/psc.818 hal-01563754

Références complètes

  1. Jean Guillon, Caroline Denevault‐sabourin, Edith Chevret, Marie Brachet‐botineau, Vittoria Milano, et al.. Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex. Archiv der Pharmazie / Chemistry in Life Sciences, Wiley-VCH Verlag, In press, ⟨10.1002/ardp.202000450⟩. ⟨hal-03279625⟩
  2. Jean Guillon, Stéphane Moreau, Vanessa Desplat, Marian Vincenzi, Noël Pinaud, et al.. Synthesis, crystal structure and anti-leukemic activity of 4-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline. Journal of Chemical Crystallography, Springer Verlag, 2019, 49 (2), pp.106-112. ⟨10.1007/s10870-018-0734-2⟩. ⟨hal-02130098⟩
  3. Jean Guillon, Anita Cohen, Rabindra Nath Das, Clotilde Boudot, Nassima Meriem Gueddouda, et al.. Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives. Chemical Biology & Drug Design, 2018, ⟨10.1111/cbdd.13164⟩. ⟨hal-01690455⟩
  4. S. Rubio, J. Clarhaut, E. Peraudeau, M. Vincenzi, C. Soum, et al.. Diminished oligomerization in the synthesis of new anti-angiogenic cyclic peptide using solution instead of solid-phase cyclization. Biopolymers, 2016, pp.368-375. ⟨10.1002/bip.22814⟩. ⟨hal-01563735⟩
  5. J. Guillon, S. Moreau, Luisa Ronga, L. Basmacyian, A. Cohen, et al.. Design, Synthesis and Antimalarial Activity of Some New minoalcoholpyrrolo[ 1,2-A]quinoxaline Derivatives. Letters in Drug Design and Discovery, 2016, 13 (9), pp.932-942. ⟨10.2174/1570180813666160517164758⟩. ⟨hal-01563736⟩
  6. Vanessa Desplat, Marian Vincenzi, Romain Lucas, Stéphane Moreau, Solène Savrimoutou, et al.. Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines. European Journal of Medicinal Chemistry, Elsevier, 2016, 113, pp.214-227. ⟨10.1016/j.ejmech.2016.02.047⟩. ⟨hal-01307573⟩
  7. M. Vincenzi, A. Accardo, S. Costantini, S. Scala, L. Portella, et al.. Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles. Molecular BioSystems, 2015, 11 (11), pp.2925-2932. ⟨10.1039/c5mb00358j⟩. ⟨hal-01563737⟩
  8. J. Guillon, N. Pinaud, M. Marchivie, Luisa Ronga, A. Benazzouz, et al.. Crystal structure of a fluoro analogue of 3,4-(methylenedioxy)amphetamine. X-Ray Structure Analysis Online, Japan Society for Analytical Chemistry's, 2015, 31 (4), pp.23-24. ⟨hal-01563739⟩
  9. Luisa Ronga, M. del Favero, A. Cohen, C. Soum, P. Le Pape, et al.. Design, synthesis and biological evaluation of novel 4- alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents - Part III. European Journal of Medicinal Chemistry, Elsevier, 2014, 81, pp.378-393. ⟨10.1016/j.ejmech.2014.05.037⟩. ⟨hal-01563740⟩
  10. Luisa Ronga, P. Verdié, P. Sanchez, Christine Enjalbal, A. Maurras, et al.. Supported oligomethionine sulfoxide and Ellman's reagent for cysteine bridges formation. Amino Acids, Springer Verlag, 2013, 44 (2), pp.733-742. ⟨10.1007/s00726-012-1397-5⟩. ⟨hal-01563741⟩
  11. C. Echalier, S. Al-Halifa, A. Kreiter, C. Enjalbal, P. Sanchez, et al.. Heating and microwave assisted SPPS of C-terminal acid peptides on trityl resin: The truth behind the yield. Amino Acids, Springer Verlag, 2013, 45 (6), pp.1395-1403. ⟨10.1007/s00726-013-1604-z⟩. ⟨hal-01563742⟩
  12. P. Verdié, Luisa Ronga, M. Cristau, M. Amblard, S. Cantel, et al.. Oxyfold: A simple and efficient solid-supported reagent for disulfide bond formation. Chemistry - An Asian Journal, 2011, 6 (9), pp.2382-2389. ⟨10.1002/asia.201100202⟩. ⟨hal-01563744⟩
  13. Luisa Ronga, A.G. Jamieson, K. Beauregard, C. Quiniou, S. Chemtob, et al.. Insertion of multiple alpha-amino gamma-lactam (Agl) residues into a peptide sequence by solid-phase synthesis on synphase lanterns.. Biopolymers, 2010, 94 (2), pp.183-191. ⟨10.1002/bip.21288⟩. ⟨hal-01563745⟩
  14. Luisa Ronga, P. Palladino, R. Ragone, J. Martinez, E. Benedetti, et al.. Spectroscopic analysis of synthetic PrP helix2-binding peptide constructs.. Advances in experimental medicine and biology, 2009, 611, pp.75-76. ⟨10.1007/978-0-387-73657-0_33⟩. ⟨hal-01563747⟩
  15. P. Palladino, Luisa Ronga, E. Benedetti, F. Rossi, R. Ragone. Peptide fragment approach to prion misfolding: The alpha-2 domain. International Journal of Peptide Research and Therapeutics, 2009, 15 (3), pp.165-176. ⟨10.1007/s10989-009-9171-6⟩. ⟨hal-01563748⟩
  16. Luisa Ronga, P. Palladino, R. Ragone, E. Benedetti, F. Rossi. A thermodynamic approach to the conformational preferences of the 180-195 segment derived from the human prion protein α2-helix. Journal of Peptide Science, 2009, 15 (1), pp.30-35. ⟨10.1002/psc.1086⟩. ⟨hal-01563746⟩
  17. Luisa Ronga, P. Palladino, G. Saviano, T. Tancredi, E. Benedetti, et al.. Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein α2-helical 180-195 segment and comparison with full-length α2-helix-derived peptides. Journal of Peptide Science, 2008, 14 (10), pp.1096-1102. ⟨10.1002/psc.1046⟩. ⟨hal-01563749⟩
  18. Luisa Ronga, E. Langella, P. Palladino, D. Marasco, B. Tizzano, et al.. Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and α helix 2 human prion protein fragments. Proteins: Structure, Function and Genetics, 2007, 66 (3), pp.707-715. ⟨10.1002/prot.21204⟩. ⟨hal-01563752⟩
  19. Luisa Ronga, P. Palladino, S. Costantini, A. Facchiano, M. Ruvo, et al.. Conformational diseases and structure-toxicity relationships: Lessons from prion-derived peptides. Current Protein and Peptide Science, 2007, 8 (1), pp.83-90. ⟨10.2174/138920307779941505⟩. ⟨hal-01563750⟩
  20. E. Benedetti, F. Rossi, Luisa Ronga, B. Tizzano, P. Palladino, et al.. The prion protein: Structural features and related toxic peptides. Chemical Biology and Drug Design, 2006, 68 (3), pp.139-147. ⟨10.1111/j.1747-0285.2006.00427.x⟩. ⟨hal-01563753⟩
  21. Luisa Ronga, P. Palladino, B. Tizzano, D. Marasco, E. Benedetti, et al.. Effect of salts on the structural behavior of hPrP α2-helix-derived analogues: The counterion perspective. Journal of Peptide Science, 2006, 12 (12), pp.790-795. ⟨10.1002/psc.818⟩. ⟨hal-01563754⟩